切换至 "中华医学电子期刊资源库"

中华移植杂志(电子版) ›› 2020, Vol. 14 ›› Issue (04) : 251 -254. doi: 10.3877/cma.j.issn.1674-3903.2020.04.013

所属专题: 文献

综述

肾脏低温携氧机械灌注研究进展
周书君1, 王彦峰1,()   
  1. 1. 430071 武汉大学中南医院移植外科 武汉大学肝胆疾病研究院
  • 收稿日期:2019-12-13 出版日期:2020-08-25
  • 通信作者: 王彦峰
  • 基金资助:
    国家自然科学基金(81570079)

Research progress of hypothermic oxygenated machine perfusion in kidney preservation

Shujun Zhou1, Yanfeng Wang1,()   

  1. 1. Department of Transplantation, Zhongnan Hospital of Wuhan University; Institute of Hepatobiliary Diseases of Wuhan University, Wuhan 430071, China
  • Received:2019-12-13 Published:2020-08-25
  • Corresponding author: Yanfeng Wang
  • About author:
    Corresponding author: Wang Yanfeng, Email:
引用本文:

周书君, 王彦峰. 肾脏低温携氧机械灌注研究进展[J/OL]. 中华移植杂志(电子版), 2020, 14(04): 251-254.

Shujun Zhou, Yanfeng Wang. Research progress of hypothermic oxygenated machine perfusion in kidney preservation[J/OL]. Chinese Journal of Transplantation(Electronic Edition), 2020, 14(04): 251-254.

肾移植是终末期肾病的最佳治疗方法。近年来,为缓解供器官短缺,边缘供肾在肾移植中的使用比例逐渐升高,对供肾保存提出了更高要求。肾脏低温携氧机械灌注(HOPE)技术具有减轻供肾缺血再灌注损伤和减少排斥反应发生的作用,受到研究人员和临床医师重视。本文就HOPE对供肾的作用和机制、氧合方式等研究进展以及存在的争议作一综述。

Kidney transplantation is the best treatment option for end-stage renal disease. In recent years, in order to alleviate the problem of donor kidneys shortage, the use of marginal donor kidneys has been increasing, which puts forward higher requirements for donor preservation. Due to its advantages of reducing ischemia reperfusion injury of marginal donors and suppressing rejection, hypothermic oxygenated machine perfusion(HOPE) has gained widely attention again. This review will focus on the progress on HOPE in kidney perservation.

1
Chatauret N, Coudroy R, Delpech PO, et al. Mechanistic analysis of nonoxygenated hypothermic machine perfusion′s protection on warm ischemic kidney uncovers greater eNOS phosphorylation and vasodilation[J]. Am J Transplant, 2014,14(11): 2500-2514.
2
Wszola M, Kwiatkowski A, Domagala P, et al. Preservation of kidneys by machine perfusion influences gene expression and may limit ischemia/reperfusion injury[J]. Prog Transplant, 2014,24(1): 19-26.
3
Kroemer G. B709 mitochondrial control of cell death[J]. ScientificWorldJournal, 2001,1: 48.
4
Jochmans I, Hofker HS, Davies L, et al. Oxygenated hypothermic machine perfusion of kidneys donated after circulatory death: an international randomised controlled trial[C]//26th Annual meeting of Belgian Transplantation Society, Antwerp, 2019.
5
Kron P, Schlegel A, Muller X, et al. Hypothermic oxygenated perfusion: a simple and effective method to modulate the immune response in kidney transplantation[J]. Transplantation, 2019,103(5): e128-e136.
6
Hoyer DP, Gallinat A, Swoboda S, et al. Influence of oxygen concentration during hypothermic machine perfusion on porcine kidneys from donation after circulatory death[J]. Transplantation, 2014,98(9): 944-950.
7
Pegg DE, Foreman J, Hunt CJ, et al. The mechanism of action of retrograde oxygen persufflation in renal preservation[J]. Transplantation, 1989,48(2): 210-217.
8
Kron P, Schlegel A, de Rougemont O, et al. Short, cool, and well oxygenated - HOPE for kidney transplantation in a rodent model[J]. Ann Surg, 2016,264(5): 815-822.
9
Darius T, Gianello P, Vergauwen M, et al. The effect on early renal function of various dynamic preservation strategies in a preclinical pig ischemia-reperfusion autotransplant model[J]. Am J Transplant, 2018,19(3): 752-762.
10
Thuillier R, Allain G, Celhay O, et al. Benefits of active oxygenation during hypothermic machine perfusion of kidneys in a preclinical model of deceased after cardiac death donors[J]. J Surg Res, 2013,184(2): 1174-1181.
11
Schlegel A, Kron P, Graf R, et al. Hypothermic oxygenated perfusion (HOPE) downregulates the immune response in a rat model of liver transplantation[J]. Ann Surg, 2014,260(5): 931-937.
12
Casiraghi F, Azzollini N, Todeschini M, et al. Complement alternative pathway deficiency in recipients protects kidney allograft from ischemia/reperfusion injury and alloreactive T cell response[J]. Am J Transplant, 2017,17(9): 2312-2325.
13
Mills EL, Kelly B, O′Neill LAJ. Mitochondria are the powerhouses of immunity[J]. Nat Immunol, 2017,18(5): 488-498.
14
Gallinat A, Paul A, Efferz P, et al. Role of oxygenation in hypothermic machine perfusion of kidneys from heart beating donors[J]. Transplantation, 2012,94(8): 809-813.
15
Venema LH, Brat A, Moers C, et al. Effects of oxygen during long-term hypothermic machine perfusion in a porcine model of kidney donation after circulatory death[J]. Transplantation, 2019,103(10): 2057-2064.
16
Rudolf LE, Mandel S. Supercooling, intermittent perfusion, and high pressure oxygen in whole organ preservation[J]. Transplantation, 1967,5(4): 1159-1166.
17
Edwards ML. Hyperbaric oxygen therapy. Part 1: history and principles[J]. J Vet Emerg Crit Care (San Antonio), 2010,20(3): 284-288.
18
Treckmann J, Nagelschmidt M, Minor T, et al. Function and quality of kidneys after cold storage, machine perfusion, or retrograde oxygen persufflation: results from a porcine autotransplantation model[J]. Cryobiology, 2009,59(1): 19-23.
19
Molácáček J, Opatrný V, Matějka R, et al. Retrograde oxygen persufflation of kidney - experiment on an animal[J]. In Vivo, 2016,30(6): 801-805.
20
Edwards ML. Hyperbaric oxygen therapy. Part 2: application in disease[J]. J Vet Emerg Crit Care (San Antonio), 2010,20(3): 289-297.
21
Patel K, Smith TB, Neil DAH, et al. The effects of oxygenation on ex vivo kidneys undergoing hypothermic machine perfusion[J]. Transplantation, 2019,103(2): 314-322.
22
Darius T, Vergauwen M, Smith TB, et al. Influence of different partial pressures of oxygen during continuous hypothermic machine perfusion in a pig kidney ischemia-reperfusion autotransplant model[J]. Transplantation, 2020,104(4): 731-743.
23
Ijichi H, Taketomi A, Soejima Y, et al. Effect of hyperbaric oxygen on cold storage of the liver in rats[J]. Liver Int, 2006,26(2): 248-253.
24
Guimarães FA, Taha MO, Simões MJ, et al. Apoptosis and nuclear proliferation in rat small bowel submitted to hypothermic hyperbaric oxygenation for preservation[J]. Transplant Proc, 2006,38(6): 1876-1878.
25
Amberson WR. Clinical experience with hemoglobin-saline solutions[J]. Science, 1947,106(2745): 117.
26
Brandhorst H, Asif S, Andersson K, et al. A new oxygen carrier for improved long-term storage of human pancreata before islet isolation[J]. Transplantation, 2010,89(2): 155-160.
27
Hosgood SA, Nicholson ML. The role of perfluorocarbon in organ preservation[J]. Transplantation, 2010,89(10): 1169-1175.
28
Marada T, Zacharovova K, Saudek F. Perfluorocarbon improves post-transplant survival and early kidney function following prolonged cold ischemia[J]. Eur Surg Res, 2010,44(3-4): 170-178.
29
Maluf DG, Mas VR, Yanek K, et al. Molecular markers in stored kidneys using perfluorocarbon-based preservation solution: preliminary results[J]. Transplant Proc, 2006,38(5): 1243-1246.
30
Hosgood SA, Mohamed IH, Nicholson ML. The two layer method does not improve the preservation of porcine kidneys[J]. Med Sci Monit, 2011,17(1): BR27-BR33.
31
Jahr JS, Guinn NR, Lowery DR, et al. Blood substitutes and oxygen therapeutics: a review[J]. Anesth Analg, 2019. [Ahead of print]
32
Vogel T, Brockmann JG, Coussios C, et al. The role of normothermic extracorporeal perfusion in minimizing ischemia reperfusion injury[J]. Transplant Rev (Orlando), 2012,26(2): 156-162.
33
Matton APM, Burlage LC, van Rijn R, et al. Normothermic machine perfusion of donor livers without the need for human blood products[J]. Liver Transpl, 2018,24(4): 528-538.
34
Laing RW, Bhogal RH, Wallace L, et al. The use of an acellular oxygen carrier in a human liver model of normothermic machine perfusion[J]. Transplantation, 2017,101(11): 2746-2756.
35
Mahboub P, Aburawi M, Karimian N, et al. The efficacy of HBOC-201 in ex situ gradual rewarming kidney perfusion in a rat model[J]. Artif Organs, 2020,44(1): 81-90.
36
Shonaka T, Matsuno N, Obara H, et al. Application of perfusate with human-derived oxygen carrier solution under subnormothermic machine perfusion for donation after cardiac death liver grafts in pigs[J]. Transplant Proc, 2018,50(9): 2821-2825.
37
Rousselot M, Delpy E, Drieu La Rochelle C, et al. Arenicola marina extracellular hemoglobin: a new promising blood substitute[J]. Biotechnol J, 2006,1(3): 333-345.
38
Le Gall T, Polard V, Rousselot M, et al. In vivo biodistribution and oxygenation potential of a new generation of oxygen carrier[J]. J Biotechnol, 2014,187: 1-9.
39
Tsai AG, Intaglietta M, Sakai H, et al. Microcirculation and NO-CO studies of a natural extracellular hemoglobin developed for an oxygen therapeutic carrier[J]. Curr Drug Discov Technol, 2012,9(3): 166-172.
40
Thuillier R, Dutheil D, Trieu MT, et al. Supplementation with a new therapeutic oxygen carrier reduces chronic fibrosis and organ dysfunction in kidney static preservation[J]. Am J Transplant, 2011,11(9): 1845-1860.
41
Kasil A, Giraud S, Couturier P, et al. Individual and combined impact of oxygen and oxygen transporter supplementation during kidney machine preservation in a porcine preclinical kidney transplantation model[J]. Int J Mol Sci, 2019,20(8): 1992.
[1] 张秋阳, 余韶芸, 潘向滢, 金家佳, 夏桦, 赵雪红. 成年体外膜肺氧合患者出血影响因素的Meta 分析[J/OL]. 中华危重症医学杂志(电子版), 2024, 17(05): 392-398.
[2] 邹永康, 石雍, 徐贤刚, 张帅民, 刘衍, 杨生鹏, 叶啟发, 陈根, 张毅. 肾移植术后手术切口米根霉感染伴菌血症一例并文献复习[J/OL]. 中华移植杂志(电子版), 2024, 18(05): 289-292.
[3] 中华医学会器官移植学分会. 遗体捐献肾脏获取手术技术操作指南[J/OL]. 中华移植杂志(电子版), 2024, 18(05): 257-265.
[4] 霍枫, 李智霞, 季茹, 谭晓宇, 范晓礼, 叶啟发. 以循环标准判定死亡的遗体器官捐献分类标准、实施流程及需要注意的问题[J/OL]. 中华移植杂志(电子版), 2024, 18(04): 213-221.
[5] 吕玥彤, 靳梦圆, 周大为, 叶啟发. 机器人辅助下肾移植的临床进展与争议[J/OL]. 中华移植杂志(电子版), 2024, 18(04): 242-246.
[6] 中华医学会器官移植学分会. 体外膜肺氧合在遗体捐献供肾保护中的应用指南[J/OL]. 中华移植杂志(电子版), 2024, 18(03): 148-158.
[7] 尚丽红, 王志华, 张文艳, 朱琳茹, 周华. 内皮粘蛋白抗体与肾移植术后抗体介导排斥反应和移植肾预后的研究[J/OL]. 中华移植杂志(电子版), 2024, 18(03): 165-170.
[8] 吕军好, 林锦雯, 张心怡, 陈江华. 细胞外囊泡在肾移植诊断和治疗中的研究进展[J/OL]. 中华移植杂志(电子版), 2024, 18(03): 186-192.
[9] 陆婷, 陈浩, 王雪静, 谭若芸, 彭宇竹. 肾移植术后一年发生代谢综合征的危险因素分析[J/OL]. 中华移植杂志(电子版), 2024, 18(02): 98-103.
[10] 郭明星, 徐烨, 徐菀佚, 赵莹, 刘冉佳, 潘晨, 崔向丽. 2017—2022年中国105家医院肾移植术后门诊受者免疫抑制剂用药分析[J/OL]. 中华移植杂志(电子版), 2024, 18(02): 104-109.
[11] 魏丁, 乔艳艳, 顾兴, 张燕, 李艳燕, 钱卫生, 潘蕾, 高永恒, 金发光. 体外膜肺氧合救治急性呼吸窘迫综合征不良预后危险因素分析[J/OL]. 中华肺部疾病杂志(电子版), 2024, 17(03): 363-367.
[12] 王晓霞, 乌丹, 张江英, 乌雅罕, 郝颖楠, 斯日古楞. 《2023 年美国胸科学会关于成人急性呼吸窘迫综合征患者管理的临床实践指南更新》解读[J/OL]. 中华重症医学电子杂志, 2024, 10(04): 338-343.
[13] 许浩, 罗亮. 体外膜肺氧合支持期间新发感染的研究进展[J/OL]. 中华重症医学电子杂志, 2024, 10(03): 292-297.
[14] 周帅, 张庆海, 王新, 马晓艳, 孙建霞, 王海波, 张继红. 静脉-动脉体外膜肺氧合辅助下溶栓治疗急性高危肺栓塞一例[J/OL]. 中华重症医学电子杂志, 2024, 10(03): 298-302.
[15] 詹维强, 李梦蝶, 涂玉玲, 郭艳, 芦乙滨, 史新格, 许明. 早期CRRT联合VA-ECMO治疗难治性心源性休克的临床效果[J/OL]. 中华卫生应急电子杂志, 2024, 10(05): 260-268.
阅读次数
全文


摘要